Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2005
11/15/2005US6965017 Melanoma antigens and their use in diagnostic and therapeutic methods
11/15/2005US6964978 Dissolving with crystal growth inihibitos; drying
11/15/2005US6964976 Amino alcohol derivatives
11/15/2005US6964971 Oral administering; sustained release
11/15/2005US6964967 Substituted pyrido[2,3-d]pyrimidines and methods for their use
11/15/2005US6964965 Corticotropin releasing factor antagonists
11/15/2005US6964962 A norepinephrine reuptake inhibitor or its salt and a neuroleptic agent
11/15/2005US6964960 Indoloquinazolinones
11/15/2005US6964956 Enzyme inhibitors of the I kappa B kinase, therapeutic treatment of autoimmune diseases, inflammatory diseases and cancer; chemical intermediates, sulfiding, sulfonation, desulfonation, cyclization
11/15/2005US6964853 Smad6 and uses thereof
11/15/2005US6964785 Herbal composition for improving anticancer activity, immune response and hematopoiesis of the body, and protecting the body from oxidative damage, and the method of preparing the same
11/15/2005US6964784 Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
11/15/2005US6964769 Molecular antigen array
11/15/2005US6964766 Peptides for use in immunotherapy of autoimmune diseases
11/10/2005WO2005105151A1 Pegylated thymosin 1 derivatives
11/10/2005WO2004069142A8 Anti-candida agents for the treatment of prion diseases
11/10/2005US20050250950 1,3-oxathiolane nucleoside analogues
11/10/2005US20050250939 Process for the production of multiple cross-linked hyaluronic acid derivatives
11/10/2005US20050250934 synthetic peptide conjugate compositions for the treatment of immunoglobulins (IgE)-mediated allergic diseases by active immunization
11/10/2005US20050250848 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
11/10/2005US20050250846 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use
11/10/2005US20050250796 Suppress tumor necrosis factor; Crohn's disease; imflammatory bowel disorders; sepsis; autoimmune disease
11/10/2005US20050250792 Substituted piperidine compounds useful as modulators of chemokine receptor activity
11/10/2005US20050250790 Novel sulfonic acid derivatives
11/10/2005US20050250760 1-[(Indol-3-yl)carbonyl]piperazine derivatives
11/10/2005US20050250727 Use of immunomodulating agents
11/10/2005US20050250723 Immunostimulation by chemically modified RNA
11/10/2005US20050250716 Immunostimulatory oligodeoxynucleotides
11/10/2005US20050250707 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
11/10/2005US20050250698 Method for obtaining a TGF-beta enriched protein fraction in activated form, protein fraction and therapeutic applications
11/10/2005US20050250697 Method for obtaining a TGF-beta enriched protein fraction in activated form, protein fraction and therapeutic applications
11/10/2005US20050250196 Recombinant microorganisms expressing an oligosaccharide receptor mimic
11/10/2005US20050250175 Bacterial cell wall skeleton component preparaion
11/10/2005US20050250120 Deleted sequences in M. bovis BCG/M bovis or M. tuberculosis, method for detecting mycobacteria using these sequences and vaccines
11/10/2005US20050249756 Use of human prostate cell lines in cancer treatment
11/10/2005US20050249722 Monoclonal antibodies with enhanced ADCC function
11/10/2005US20050249714 Method of using secretin and compositions made therefrom for the treatment of autism and other neurological, behavioral and immunological disorders
11/10/2005US20050249710 biodegradable drug delivery system containing an immunosuppressive agent and a bioerodible polymer comprising hydroxyaliphatic carboxylic acids, and polysaccharides
11/10/2005US20050249707 Stimulating an immune response in human or animal, by administering a gene, infected DENDRITIC CELLS; without preventing antigen processing occurring within the infected cell; increase gene expression on the surface of tumour cells; protection against cancer; vaccines
11/10/2005US20050249705 Inactivated herpes simplex virus glycoprotein for treating metastasis; ultraviolet radiation and heating; highly safe
11/10/2005US20050249704 Method of treating autoimmune diseases with interferon-beta and il-2r antagonist
11/10/2005US20050249701 Il-7 Drug substance, composition, preparation and uses
11/10/2005US20050249700 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
11/10/2005US20050249698 Synergistic effect of the osteogenic growth peptide and the granulocyte clony stimulating factor on haematogenesis
11/10/2005DE10112926B4 Verwendung von Aminooxyacetat zur Tumorbehandlung Use of aminooxyacetate for tumor treatment
11/10/2005CA2563569A1 Combinations comprising a s1p receptor agonist and a jak3 kinase inhibitor
11/09/2005EP1593681A1 Tricyclic compound, process for producing the same, and use
11/09/2005EP1593680A1 Fused-ring pyridine derivative, process for producing the same, and use
11/09/2005EP1593673A1 Acrylamide derivative, process for producing the same, and use
11/09/2005EP1593664A1 Nitric esters derivatives of ferulic acid and sulindac with pharmaceutical activity
11/09/2005EP1593393A2 Anti-TNF antibodies and methotrexate in the treatment of autoimmune diseases
11/09/2005EP1593386A1 Use of galectin-2
11/09/2005EP1593383A1 Lotus plant extract with antihistaminic activity
11/09/2005EP1593382A1 Use of probiotic lactic bacteria for balancing the skin's immune system
11/09/2005EP1593379A2 Uses of PPAR-gamma agonists in neutrophil-induced diseases
11/09/2005EP1592777A2 A method for generating high affinity antibodies
11/09/2005EP1592776A2 HIGH AFFINITY ANTI-HUMAN IgE ANTIBODIES
11/09/2005EP1592680A1 2-phenylpyran-4-one derivatives as selective cox-2 inhibitors
11/09/2005EP1592452A2 Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology
11/09/2005EP1592449A2 Sensitizing cells for apoptosis by selectively blocking cytokines
11/09/2005EP1592384A2 Cop 1 for treatment of inflammatory bowel diseases
11/09/2005EP1501787B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
11/09/2005EP1405083B1 Natural ligand of gpcr chemr23 and uses thereof
11/09/2005EP1297172B1 Methods for producing modified glycoproteins
11/09/2005EP1287142B1 Nucleic acid molecule comprising a nucleic acid sequence coding for an sdf-1 gamma chemokine, a neuropeptide precursor or at least one neuropeptide
11/09/2005EP1254118B1 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
11/09/2005EP1218376B1 Tyrosine kinase inhibitors
11/09/2005EP1214325B1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
11/09/2005EP1212421B1 Gas1 polypeptides
11/09/2005EP1212296B1 Phosphate mimics and methods of treatment using phosphatase inhibitors
11/09/2005EP1202974B1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/09/2005EP1163236B1 Aromatic heterocyclic compounds as anti-inflammatory agents
11/09/2005EP1144371B1 Benzenesulphonamide derivatives and their use as mek inhibitors
11/09/2005EP1075519B1 Inhibitors of nf-kb activation
11/09/2005EP1049700B1 Chemokine receptor antagonists and methods of use therefor
11/09/2005EP1019089B1 Long-acting drugs and pharmaceutical compositions comprising them
11/09/2005EP0808330B1 A process for preparing certain aza cyclohexapeptides
11/09/2005CN1694900A EE3-protein family and corresponding DNA sequences
11/09/2005CN1694894A Anti-IL-6 antibodies, compositions, methods and uses
11/09/2005CN1694879A Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same
11/09/2005CN1694875A 5-aryltetrazole compounds and uses thereof
11/09/2005CN1694736A Medical devices containing rapamycin analogs
11/09/2005CN1694722A A process for the preparation of a non-toxic anthrax vaccine
11/09/2005CN1694719A Casein derived peptides and uses thereof in therapy
11/09/2005CN1694703A Use of indolyl derivatives for the manufacture of a medicament for the treatment allergic rhinitis
11/09/2005CN1694490A Method, equipment and computer program of changed digital color image
11/09/2005CN1226290C Ligands of nuclear receptor
11/09/2005CN1226044C Oral liquid for relieving rheumatic pains and stopping itch, and its preparation method
11/08/2005US6963012 2-amino-2-[4-(3-benzyloxyphenoxy)-2-chlorophenyl]propyl-1,3-propanediol for example; treating autoimmune diseases such as rheumatoid arthritis, transplant rejection, psoriasis, dermatitis
11/08/2005US6963011 Central nervous system disorders; psychological disorders
11/08/2005US6963010 Hydrophobic polyamine analogs and methods for their use
11/08/2005US6962996 Inhibitors of p38
11/08/2005US6962993 Useful as inhibitors of protein kinases, such as the enzyme Janus Kinase 3
11/08/2005US6962978 Multiple sclerosis; immobilization; water solubility
11/08/2005US6962972 Active material; denaturing protein; hybrid enzyme
11/08/2005US6962941 such as 1,4-Bis-{N-[3-(3-aminomethylphenylproplonyl)-2-methoxycarbonylpyrrolidin-4-yl]aminocarbonyloxy}-2-butyne dihydrochloride; for treatment of asthma, allergic conjunctivitis, allergic rhinitis, psoriasis, and ulcerative colitis
11/08/2005US6962937 Imidazolidine derivatives, their preparation and their use
11/08/2005US6962936 Treating diseases such as cancer, inflammatory disorders, restenosis,
11/08/2005US6962933 cerebral hemorrhage/infarction, head trauma, spinal cord injury, brain edema, multiple sclerosis, Alzheimer's/Parkinson's disease, amyotrophic lateral sclerosis, diabetes, osteoporosis, Creutzfeldt-Jakob disease or virus infections
11/08/2005US6962924 Antihistamines; side effect reduction